A linear strategy was adopted in synthesizing the novel amine derivatives 7(a-h) of 5-[5-(chloromethyl)-1, 3, 4-oxadiazol-2-yl]-2-(4-fluorophenyl)-pyridine (6) and screened these compounds for in vitro anticancer activity against three human cancer cell lines (HeLa,Caco-2 and HepG2). The synthesised novel compounds were characterized by 1 H NMR, MS and 13 C NMR spectroscopic evidences. Microwave irradiation of compound (5) 
INTRODUCTION
As per literature review, various analogues of 2, 5-disubstituted-1, 3,4-oxadiazole derivatives of pyridine ( Figure 1 ,C) have been studied for their analgesic, anti-inflammatory 1 , antimicrobial 2, 3 , antitumor 4 and anticancer 5 properties. Substitution of 4-fluorophenyl group at second position of the pyridine containing 1,3,4-oxadiazolesmoiety 6 has shown very good cytotoxicity against human cancer cell lines 7 . In view of this, novel amine derivatives of 5-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]-2-(4-fluorophenyl)-pyridine ( Figure 1 , A) have been designed and synthesised. These novel 1,3,4-oxadia-zole amine compounds 7(a-h) were obtained from compound (6) which was prepared from (5) by the in situ dehydration and cyclization reaction using phosphoryl oxychloride and chloroacetic acid under microwave irradiation. The intermediate carbohydrazide (5) was completely converted into product (6) in the form of a solid by subsequent neutralization. The starting material used for this synthetic pathway was 6-bromonicotinic acid (1) which was converted to 6-(4-fluorophenyl) nicotinic acid ethyl ester 8 (4) by treating the ethyl ester (3) with 4-fluorophenyl boronic acid in presence of tetra bis (triphenyl phosphine) palladium (0) in ethanol. The ester (4) thus obtained was converted into the corresponding hydrazide (5) by treating with hydrazine hydrate. 9 The novel amine derivatives 7(ah) obtained by refluxing compound (6) with primary or secondary amines in deoxan and TEA were purified by column chromatography (silica gel 100-200 mesh) and characterized by 1 H NMR, 13 C NMR and MS spectroscopic analyses. The percentage yield of all the final compounds was found to be in the range 48-88% and purity in between 94-97%. The scheme of reactions from compound 1-6 is shown in figure 2 . The conversion of compound (6) to amine derivatives, 7(a-h) have been given in figure 3 . It was envisaged that the novel amine derivatives of 1, 3, 4-oxadiazole (Figure 1, B) would enhance the solubility, total polar surface area (TPSA) and bioavailability. With this view the compounds have been subjected to MTT assay 10 for testing their cytotoxic activity using 5-fluorouracil as the standard drug. Three human carcinoma cell lines were employed for the screening and the activity was calculated in terms of the IC 50 values. Some of the synthesized 1,3,4-oxadiazoles were found to exhibit better cytotoxicity against HepG2 and Caco-2cell lines. 
MATERIALS AND METHODS
All reagents, chemicals and solvents were purchased from S-D fine and Spectrochem Ltd., Bangalore, India.
1 H-and 13 C-NMR were recorded by Brucker 400 MHz spectrophotometer. Melting points were determined using Buchi melting point apparatus 545. Mass spectra were recorded by Agilent 1200 series. TLC was done on F 254 grade silica 60 from Merck. All the final and intermediate compounds were purified by normal glass column using silica gel 100-200 mesh. IR spectra were recorded by FTIR (1800S) series. Microwave reaction was carried out using Whirlpool semi-automated microwave.
Synthesis of 6-bromo-nicotinic acid (2). 2-Bromo-5-methyl-pyridine (15 g, 0.0873 mol) was taken in 1L RB flask containing 100 ml of water and 100 ml of pyridine. KOH (14.65 g, 0.0261 mol) and KMnO 4 (68.96 g, 0.0436 mol) were added to this reaction mixture and it was refluxed at 85°C overnight. After completion of the reaction as observed by TLC, solvent was removed, residue was diluted with water (100-150 ml) and filtered. 
Synthesis of 6-(4-fluorophenyl)-nicotinic acid ethyl ester (4).
A mixture of 6-bromonicotinic acid ethyl ester (3) (8.5 g, 0.0369 mol), K 2 CO 3 (15.27 g, 0.1107 mol), tetrabis triphenyl palladium (0) (0.213 g, 0.000185 mol) and 4-fluorophenylboronic acid (5.166 g, 0.0369 mol) were refluxed at 85°C in ethanol for 3-5 hrs (Suzuki-Mayora coupling reaction). After completion of the reaction as per the TLC monitoring, solvent was removed, residue was diluted with water and the product was extracted with ethyl acetate (25 ml × 4), washed with brine (10 ml) and dried over Na 2 
Synthesis of 6-(4-fluorophenyl)-nicotinic acid hydrazide (5).
A mixture of 6-(4-fluorophenyl) nicotinic acid ethyl ester (4) (5.2 g, 0.0211 mol), 10 ml of hydrazine hydrate and 50 ml of ethanol was refluxed for overnight at 80°C. After completion of the reaction, solvent was removed and few ice pieces and saturated brine solution were added to the residue. Solid that separated out was filtered, washed with 10 ml of water and dried. 
Synthesis of 5-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]-2-(4-fluorophenyl)-pyridine (6).
A 200 ml flask containing compound (4) (3.1 g, 1 mmol), phosphoryl oxychloride and chloroacetic acid was irradiated with microwave for a period of 5 minutes. TLC was monitored to check the completion. After completion of the reaction ice cold water was added to the mixture and neutralised with a saturated solution of Na 2 CO 3 . The separated solid was filtered, washed with 10 ml of water and dried. 
General procedure for the synthesis of amine derivatives of 5-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]-2-(4-fluorophenyl)-pyridine(7a-h).
Compound (6) (200 mg, 1 mmol) was added to a mixture of 1, 4-dioxin (10 ml), TEA (2 ml) and the corresponding amines (a-h, 1.1 mmol) refluxed for 3-8 hrs. TLC was used to check the completion of the reaction. After completion, the solvent was removed, residue was diluted with water (10 ml) and the product was extracted with ethyl acetate (10 ml × 2), washed with brine (10 ml) and dried over anhydrous Na 2 SO 4 . The crude product was purified by column chromatography (silica gel 100-200 mesh) using ethyl acetate-hexane (50 : 50). 
1-{5-[6-(4-Fluorophenyl)-pyridin-3-yl]-[1,3,4] oxadiazol-2-yl-methyl}-4-pyridin-2-yl-piperazine (7c

Diethyl-{5-[6-(4-fluorophenyl)-pyridin-3-yl]-[1,3,4] oxadiazol-2-yl-methyl}-amine (7d
{5-[6-(4-Fluorophenyl)-pyridin-3-yl]-[1,3,4] oxadiazol-2-yl-methyl}-phenyl-amine(7f
Cytotoxic evaluation
MTT assay. Cytotoxicity of the novel amine derivatives of 1, 3, 4-oxadiazoles has been determined using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay which was carried out at Genelon Institute of Life Sciences Pvt. Ltd. The in vitro anti-proliferative MTT assay was performed against three human carcinoma cell lines namely, HeLa, Caco-2 and HepG2. All the cell lines were grown in DMEM-HG supplemented with 10% heat-inactivated FBS, 2% penicillin-streptomycin and 2.5 µg/ml amphotericin-B solutions (all from HI Media Labs, Mumbai, India). Cell lines were incubated at 37°C in a humidified atmosphere with 95% air, 5% CO 2 . Following 24-48 hrs of incubation period, the adherent cells were detached using Trypsin-EDTA solution. Cell count was done using the Luna automated cell counter (Logos Bio systems, India) based on trypan blue dye exclusion method.
Cell viability assay. The MTT assay was carried out using the following procedure. Cell suspension (200 µl) was seeded in 96-well micro plates (Corning®, USA) at a density of 25,000 cells/well and incubated for 24 hrs. All cells were seeded in duplicates with novel compounds 7a-7h having range of concentrations from 50-500 µM, incubated in a CO 2 incubator at 37°C. Treated cells were there after incubated with 10% MTT (5 mg/ml; HI Media Labs, Mumbai, India) for 3 hrs. The culture medium was then aspirated and 200 µl dimethyl sulfoxide (DMSO; Sigma-Aldrich, India) was added to it. 5-Fluorouracil (5-FU) was used as the standard. Cell viability was determined by measuring the absorbance on a micro plate reader (BMG Labtech, Germany) at 570 nm and calculated as a percentage of viable cells at different test concentrations relative to the control (5-FU).
[% cell viability = (A 570 of treated cells / A 570 of control cells) ×100%].
RESULTS AND DISCUSSION
A series of novel derivatives of 2-(4-fluorophenyl)-5-(5-aryl substituted-1,3,4-oxadiazol-2-yl) pyridine (7a-h) were synthesized, characterized and evaluated for their cytotoxic effect 11 Concentration of compound at 50% of the remaining viable cells. 
CONCLUSION
In the present study novel amine derivatives of 2-(4-fluorophenyl)-5-(5-aryl substituted-1,3,4-oxadiazol-2-yl) pyridine have been synthesised. These compounds have showed good cytotoxicity against HepG2 and Caco-2 cell lines. The IC 50 values of the compounds7aand 7d against HepG2 was found to be 2.6 µM (SI 13.06) and 5.8 µM (SI 19.31), respectively. On Caco-2 cell lines the compound 7f exhibited good cytotoxicity having IC 50 2.3µM and CC 50 87µM (SI 37.8).
